The first non-drug treatment for attention deficit hyperactivity disorder (ADHD) – a device that stimulates the trigeminal nerve – has been approved by the US Food and Drug Administration.
Called the Monarch external trigeminal nerve stimulation (eTNS) system, it is intended to be used in the home under the supervision of a caregiver. The prescription-only device is indicated for patients from seven to 12 years of age who have been diagnosed with ADHD but are not taking a drug treatment.